Alexander P. Reiner focuses mostly in the field of Wireless, narrowing it down to matters related to Telecommunications and, in some cases, Extremely high frequency. Extremely high frequency is often connected to Telecommunications in his work. Alexander P. Reiner links relevant study fields such as Quantum, Nanoscopic scale and Acoustic wave in the subject of Quantum mechanics. He conducted interdisciplinary study in his works that combined Quantum and Quantum mechanics. His Acoustics study frequently links to other fields, such as Surface acoustic wave and Acoustic wave. Alexander P. Reiner incorporates Surface acoustic wave and Acoustics in his studies. A majority of his Nanotechnology research is a blend of other scientific areas, such as Nanoscopic scale and Engineering physics. He integrates many fields in his works, including Engineering physics and Nanotechnology. His research on Immunology frequently links to adjacent areas such as Tumor necrosis factor alpha.
Genetics is often connected to Annotation in his work. His study deals with a combination of Annotation and Genome. Alexander P. Reiner conducts interdisciplinary study in the fields of Genome and Whole genome sequencing through his research. His study deals with a combination of Gene and Computational biology. His study deals with a combination of Computational biology and Genetics. His Meta-analysis research extends to the thematically linked field of Internal medicine. In his articles, he combines various disciplines, including Single-nucleotide polymorphism and Bioinformatics. He undertakes interdisciplinary study in the fields of Bioinformatics and Single-nucleotide polymorphism through his works. Alexander P. Reiner undertakes interdisciplinary study in the fields of Genotype and Locus (genetics) through his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
Mark J. Rieder;Alexander P. Reiner;Brian F. Gage;Deborah A. Nickerson.
The New England Journal of Medicine (2005)
An epigenetic biomarker of aging for lifespan and healthspan
Morgan E. Levine;Ake T. Lu;Austin Quach;Brian H. Chen.
Aging (Albany NY) (2018)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
D I Swerdlow;M V Holmes;K B Kuchenbaecker.
The Lancet (2012)
Loss-of-function mutations in APOC3, triglycerides, and coronary disease
Jacy Crosby;Gina M. Peloso;Gina M. Peloso;Paul L. Auer;David R. Crosslin.
The New England Journal of Medicine (2014)
Association between alcohol and cardiovascular disease:Mendelian randomisation analysis based on individual participant data
Michael V Holmes;Michael V Holmes;Caroline E Dale;Luisa Zuccolo;Richard J Silverwood.
DNA methylation-based measures of biological age: meta-analysis predicting time to death
Brian H. Chen;Riccardo E. Marioni;Riccardo E. Marioni;Elena Colicino;Marjolein J. Peters.
Aging (Albany NY) , 8 (9) pp. 1844-1865. (2016) (2016)
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
Ron Do;Ron Do;Nathan O. Stitziel;Hong Hee Won;Hong Hee Won;Anders Berg Jørgensen.
DNA methylation GrimAge strongly predicts lifespan and healthspan.
Ake T. Lu;Austin Quach;James G. Wilson;Alex P. Reiner.
Aging (Albany NY) (2019)
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.
Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes.
The Lancet (2015)
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.
Daniel Taliun;Daniel N. Harris;Michael D. Kessler;Jedidiah Carlson;Jedidiah Carlson.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: